<DOC>
<DOCNO>
EP-0014493
</DOCNO>
<TEXT>
<DATE>
19800820
</DATE>
<IPC-CLASSIFICATIONS>
A61P-3/06 C07C-205/00 A61K-31/4418 A61P-3/00 A61K-31/195 C07D-213/00 C07C-59/00 C07C-69/612 C07C-201/00 A61K-31/44 C07C-67/00 A61K-31/22 C07C-51/00 A61K-31/215 C07C-69/712 C07C-79/46 A61K-31/4406 A61K-31/19 A61K-31/185 C07C-59/125 C07C-69/00 <main>C07C-69/712</main> A61K-31/21 C07C-205/37 C07D-213/30 C07C-59/68 
</IPC-CLASSIFICATIONS>
<TITLE>
chlorobenzyl phenoxy alkanoic compounds.
</TITLE>
<APPLICANT>
siegfried agch<sep>siegfried aktiengesellschaft<sep>siegfried aktiengesellschaftch-4800 zofingench<sep>siegfried aktiengesellschaft  <sep>
</APPLICANT>
<INVENTOR>
adrian rudolf dr<sep>ahmed quazi dr<sep>jahn ulrich dr<sep>thiele kurt dr<sep>adrian, rudolf, dr.<sep>ahmed, quazi, dr.<sep>jahn, ulrich, dr.<sep>thiele, kurt, dr.<sep>adrian, rudolf, dr.rümlisberg 470ch-4803 vordemwaldch<sep>ahmed, quazi, dr.rigiweg 5ch-4800 zofingench<sep>jahn, ulrich, dr.kirchmoosstrasse 13ch-4800 zofingench<sep>thiele, kurt, dr.rebbergstrasse 47ch-4800 zofingench<sep>adrian, rudolf, dr.<sep>ahmed, quazi, dr.<sep>jahn, ulrich, dr.<sep>thiele, kurt, dr.<sep>adrian, rudolf, dr.rümlisberg 470ch-4803 vordemwaldch<sep>ahmed, quazi, dr.rigiweg 5ch-4800 zofingench<sep>jahn, ulrich, dr.kirchmoosstrasse 13ch-4800 zofingench<sep>thiele, kurt, dr.rebbergstrasse 47ch-4800 zofingench<sep>
</INVENTOR>
<ABSTRACT>
compounds of formula (1)    wherein r¹ and r² are the same or different lower alkyls, r³ is  hydrogen, a lower alkyl optionally substituted with a nit­ rogen-containing basic group or an ion of a pharmaceutically  acceptable metal, and r⁴ is hydrogen or nitro; and the acid  addition salts of said formula (1) compounds with  pharmaceutically acceptable acids when r³ comprises a nit­ rogen-containing basic group.  when r⁴ is nitro, r¹ and/or r²  may also represent hydrogen.  these compounds are useful in the treatment of  hypercholesterolemia and hyperlipidemia because of their  high effectiveness in reducing the level of cholesterol and  lipids in the blood combined with very low general toxicities  and substantially reduced hepatomegalitic effects.  
</ABSTRACT>
</TEXT>
</DOC>
